Avi Oler | Vice President, Corporate Development and General Counsel |
Steve Fruchtman | President and Chief Executive Officer |
Mark Guerin | Chief Financial Officer |
Ric Woodman | Chief Medical Officer and Senior Vice President, Research and Development |
Joe Pantginis | H.C. Wainwright |
Naureen Quibria | Maxim Group |
Ahu Demir | Noble Capital |
Yale Jen | Laidlaw & Company |
Good afternoon. And welcome to the Onconova Therapeutics Corporate Update and 2Q, 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference call is being recorded. At this time, I would now like to turn the call over to Avi Oler, Senior Vice President of Corporate Development and General Counsel.